Advertisement

Topics

PureTech Health and Roche Sign Collaboration Deal Worth $1 Billion-Plus

20:00 EDT 19 Jul 2018 | BioSpace

Boston-based PureTech Health inked a multi-year collaboration deal with Swiss-based Roche to advance PureTech’s milk-derived exosome platform technology for oral dosing of Roche’s antisense oligonucleotide platform.

Original Article: PureTech Health and Roche Sign Collaboration Deal Worth $1 Billion-Plus

NEXT ARTICLE

More From BioPortfolio on "PureTech Health and Roche Sign Collaboration Deal Worth $1 Billion-Plus"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...